How a Small Change in Herpesvirus Polymerase Affects Disease in Horses
Author Information
Author(s): Laura B. Goodman, Arianna Loregian, Gillian A. Perkins, Josie Nugent, Elizabeth L. Buckles, Beatrice Mercorelli, Julia H. Kydd, Giorgio Palù, Ken C. Smith, Nikolaus Osterrieder, Nicholas Davis-Poynter
Primary Institution: Cornell University
Hypothesis
Does a single amino acid change in the herpesvirus polymerase influence its ability to cause neurological disease?
Conclusion
A single amino acid variation in a herpesvirus enzyme can influence its potential to cause neurological disease without significantly affecting virus shedding.
Supporting Evidence
- The N752 mutant virus caused no neurologic signs in horses, while the D752 virus caused inflammation of the central nervous system.
- Viremia levels were significantly higher in the D752 group compared to the N752 group.
- Both viruses replicated similarly in vitro, but showed differences in their effects on leukocyte tropism.
Takeaway
This study shows that changing just one tiny part of a virus can make it less likely to make horses sick, even though it can still spread between them.
Methodology
The study involved creating recombinant viruses with different polymerase sequences and testing their effects in horses and mice.
Limitations
The study did not assess detailed neurological signs in the pony experiment, and the mouse model may not fully represent EHV-1 neuropathogenicity.
Participant Demographics
The study included Welsh mountain ponies and mixed-breed horses aged 2 to 16 years.
Statistical Information
P-Value
p = 0.01
Confidence Interval
95% confidence interval for median duration: 3–5 d for N752 and 5–6 d for D752
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website